Neurocrine Biosciences (FRA:NB3) Interest Expense : €-130 Mil (TTM As of Sep. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Neurocrine Biosciences's interest expense for the three months ended in Sep. 2024 was € 0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-130 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Neurocrine Biosciences's Operating Income for the three months ended in Sep. 2024 was € 167 Mil. Neurocrine Biosciences's Interest Expense for the three months ended in Sep. 2024 was € 0 Mil. GuruFocus does not calculate Neurocrine Biosciences's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Neurocrine Biosciences Interest Expense Historical Data

The historical data trend for Neurocrine Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Interest Expense Chart

Neurocrine Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-28.80

-26.96

-22.83

-6.70

-4.22

Neurocrine Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-1.03	-1.01	-82.62	-46.17	-

Neurocrine Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-130 Mil.

Neurocrine Biosciences (FRA:NB3) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Neurocrine Biosciences's Interest Expense for the three months ended in Sep. 2024 was €0 Mil. Its Operating Income for the three months ended in Sep. 2024 was €167 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €227 Mil.

Neurocrine Biosciences's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

GuruFocus does not calculate Neurocrine Biosciences's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Neurocrine Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

NBIX:USA 0K6R:UK NB3:Germany N1BI34:Brazil

Address

12780 El Camino Real, San Diego, CA, USA, 92130

Website

https://www.neurocrine.com

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences Headlines

No Headlines